UNSPSC 51281649: Gentamicin a

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H36N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4W8R3URS2H, chemically known as d-streptamine, o-2-amino-2-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-3-(methylamino)-.alpha.-d-xylopyranosyl-(1->6))-2-deoxy-, but more generally known as gentamicin a, which bears US NIH Compound Identifier 86474.

European Medicines Agency schedules gentamicin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02326MIG. Most nations, for tariff purposes, schedule gentamicin a under HS 29419000. SMILES: CN[C@H]1[C@H](CO[C@@H]([C@@H]1O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)N)N)N)O.

UNSPSC 51281649 Gentamicin a is a Commodity code that in recent state and local procurement activity covers pharmaceutical products procured through cooperative purchasing agreements and direct competitive bidding. The source shows minimal recent activity specifically tagged to this code; the two most recent records—an Illinois Department of Public Health piggyback pharmaceutical warehouse contract awarded to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems—do not match the gentamicin product scope. State and local health departments and county health authorities are the primary issuing bodies for pharmaceutical procurement under this general category, typically leveraging cooperative purchasing vehicles such as MMCAP Infuse consortiums to aggregate volume and reduce costs.

Recent activity under codes in this pharmaceutical family shows issuing bodies concentrated in Florida and Illinois, with contract structures involving initial terms of 12 to 24 months plus renewal options and pricing negotiated on a fixed-fee per-unit basis. The Illinois Department of Public Health piggyback award to Chartwell Rx LLC, posted August 28, 2026, with a due date of September 11, 2026, reflected a $2,999,999.11 total contract value over three years and was selected through an Invitation for Bid process without set-aside or domestic-preference requirements. The Seminole County procurement, posted June 30, 2026, required quarterly deliveries and compliance with federal auditing and clean-air regulations when FEMA funding was involved. No active open solicitations specifically for gentamicin or directly comparable pharmaceutical items appear in the source.